These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9675615)

  • 1. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
    Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
    Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
    Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
    J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
    Murakoshi M; Ikada R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
    Orima H; Shimizu M; Tsutsui T; Kawakami E; Ogasa A
    J Vet Med Sci; 1995 Feb; 57(1):139-41. PubMed ID: 7538794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
    Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
    Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of prostatic hypertrophy by osaterone acetate in dogs.
    Tsutsu T; Hori T; Shimizu M; Orima H; Kawakami E; Fukuda S
    J Vet Med Sci; 2000 Oct; 62(10):1115-9. PubMed ID: 11073087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
    Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
    J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M; Ikeda R; Fukui N; Nakayama T
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
    Murakoshi M; Ikeda R; Fukui N
    J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
    Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
    J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
    Murakoshi M; Inada R; Tagawa M; Makino M; Suzuki M; Mieda M; Honma S; Takezawa Y; Yamanaka H
    Acta Pathol Jpn; 1992 Mar; 42(3):151-7. PubMed ID: 1373927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].
    Kimura A; Higuchi T
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1697-702. PubMed ID: 2471862
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
    Murakoshi M; Tagawa M; Ikeda R
    J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
    Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
    Socha P; Zduńczyk S; Tobolski D; Janowski T
    Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
    Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
    Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
    Fujimoto K; Hirao Y; Ohashi Y; Shibata Y; Fuji K; Tsuji H; Shimizu N; Miyazawa K; Nagata M; Ohtani N; Furuya R; Boku E
    Hinyokika Kiyo; 2011 Apr; 57(4):177-83. PubMed ID: 21646847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.